Health
Up Is Down — Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval – nejm.org
Perspective from The New England Journal of Medicine — Up Is Down — Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval

Nine pharmaceutical company leaders took the unprecedented step on September 8, 2020, of stating that they would refuse to apply for approval of a Covid-19 vaccine until adequate trial data are available.1 This announcement reflected an unusual role reversal at a time of unexpected regulatory anomalies. For decades, manufacturers have criticized the Food and Drug Administration (FDA) for being too slow and demanding too much evidence before approving new products. But in the face of growing publ…
-
Noosa News20 hours ago
Katter and pregnant wife crash-land plane in outback Qld
-
Noosa News20 hours ago
Following Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Noosa News22 hours ago
Multibillion-dollar development delayed, date for Riverwalk reopening revealed
-
General16 hours ago
Russia launches hundreds of drones and missiles against Ukraine in fresh attack